| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 01/30/2007 | CA2265615C Reflux inhibitors |
| 01/25/2007 | WO2007010858A1 Pluripotent stem cell cloned from single cell derived from skeletal muscle tissue |
| 01/25/2007 | WO2007010383A1 Novel heterocyclidene acetamide derivative |
| 01/25/2007 | WO2007009772A1 Thiocolchicoside analogues with myorelaxant and anti-inflammatory activity |
| 01/25/2007 | WO2005123128A3 Methods for treating conditions associated with masp-2 dependent complement activation |
| 01/25/2007 | US20070021483 Amidine derivatives for treating amyloidosis |
| 01/25/2007 | US20070021476 Neuroprotectants; treatment of neuropathies resulting from chemtherapeutic agents used in the treatment of HIV and proliferative disease such as cancer and treatment of inflammatory diseases; neurodegenerative diseases; enzyme inhibitors for seine/threonine kinases, phosphatases; Alzheimer' |
| 01/25/2007 | US20070021427 Novel tricyclic derivatives and their use |
| 01/25/2007 | US20070021416 Imidazo[2,1-b]-1,3,4-thiadiazole sulfonamides |
| 01/25/2007 | US20070020673 Model of autoimmune disease and methods for identifying agents against autoimmune disease |
| 01/25/2007 | US20070020265 administering non-blocking anti-CD20 antibody and carrier; fusion proteins; rheumatoid arthritis |
| 01/25/2007 | US20070020260 Glycoprotein compositions |
| 01/25/2007 | CA2615860A1 Thiocolchicoside analogues with myorelaxant and anti-inflammatory activity |
| 01/24/2007 | EP1056845B1 Immunological compositions to modulate myostatin in vertebrate subjects |
| 01/24/2007 | CN1296039C Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| 01/23/2007 | US7166631 E-series of prostaglandin (EP) receptors; e.g [[4-(4,9-dipropoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl) phenyl]acetic acid |
| 01/23/2007 | US7166625 Method for treating fibrotic diseases and other indications |
| 01/23/2007 | US7166623 Pain and inflammation |
| 01/23/2007 | US7166614 CCR-2 modulators; INFLAMMATORY, IMMUNOREGULATORY, ALLERGIC, AND AUTOIMMUNE DISORDERS AND DISEASES |
| 01/23/2007 | US7166586 Sulfonamide lactam inhibitors of FXa and method |
| 01/23/2007 | US7166467 Nucleic acids, polypeptides, compositions, and methods for modulating apoptosis |
| 01/18/2007 | WO2007007688A1 3,5-diamino-1,2,4-triazole derivative |
| 01/18/2007 | WO2006107902A9 Use of spirostenols to treat mitochondrial disorders |
| 01/18/2007 | US20070015820 1,3-Diacetyl-8-hydroxy-2-(7-hydroxychromanon-3-yl)-9H-xanthen-9-ones; obtained from a culture of the Penicillium strain SPF-3059; prevents growth cone collapse |
| 01/18/2007 | US20070015755 Novel compounds and compositions as protease inhibitors |
| 01/18/2007 | US20070015202 Atlastin |
| 01/18/2007 | US20070014818 Liquid formulations with high concentration of human growth hormone (HGH) comprising 1,2-propylene glycol |
| 01/18/2007 | US20070014737 Administering quinine, chlorzoxazone, cyclobenzaprine, carisoprodol via vaporization |
| 01/17/2007 | EP1743895A1 Muscle relaxation accelerator and therapeutic agent for muscular tissue diseases such as muscle relaxation failure |
| 01/17/2007 | CN1895670A Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies, as therapeutic agents for the treatment of immunological diseases |
| 01/16/2007 | US7163960 Treatment and prevention of inflammatory disorders |
| 01/16/2007 | US7163951 N-biarylmethyl aminocycloalkanecarboxamide derivatives |
| 01/16/2007 | US7163824 Cell containing nucleic acid molecule comprising polynucleotide sequence encoding engineered zinc finger protein operably linked to promoter, contacting target site in endogenous cellular gene with protein to inhibit transcription |
| 01/16/2007 | US7163681 Isolated monoclonal antibody comprising a light and heavy chain variable of given sequence; diagnosing, treating and preventing prostate/colon cancer and renal carcinoma |
| 01/11/2007 | WO2006074390A3 Methods of treating obesity with combination therapeautics of igf-i fusion polypeptides |
| 01/11/2007 | US20070010526 Therapeutic isoquinoline compounds |
| 01/11/2007 | US20070010517 Pharmaceutical salts of reboxetine |
| 01/11/2007 | US20070010515 [1,2,4] Triazolo [1,5, a] pyrimidin-2-ylurea derivative and use thereof |
| 01/11/2007 | US20070010479 Administering pyrimidine nucleotide precursor where respiratory chain dysfunction is caused by mutation, deletion, or rearrangement of mitochondrial DNA, cytotoxic cancer chemotherapy agents, aging |
| 01/11/2007 | US20070010457 Caspase inhibitors and uses thereof |
| 01/11/2007 | US20070009554 Biologically active hemagglutinin from type a clostridium botulinum and methods of use |
| 01/10/2007 | EP1741433A1 Pharmaceutical composition comprising an androgen |
| 01/10/2007 | EP1740198A2 Anti-aging effects of substance p |
| 01/10/2007 | EP1453505A4 Use of pramipexole to treat amyotrophic lateral sclerosis |
| 01/10/2007 | EP1417227B1 Peptides eefective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/10/2007 | EP1200073B1 SELECTIVE iGluR 5? RECEPTOR ANTAGONISTS FOR THE TREATMENT OF MIGRAINE |
| 01/10/2007 | EP1109803B1 Substituted imidazoles having cytokine inhibitory activity |
| 01/10/2007 | CN1893961A Biologically active blood serum obtained by electroshock |
| 01/10/2007 | CN1294117C Amidino compound and salts thereof useful as nitric oxide synahase inhibitors |
| 01/10/2007 | CN1293877C Neurotrophic tacrolimus analogs |
| 01/09/2007 | US7160872 Methods to treat conditions mediated by chemokine receptors |
| 01/09/2007 | CA2338276C Fkbp inhibitors |
| 01/09/2007 | CA2260145C Use of l-acetylcarnitine, l-isovalerylcarnitine, l-propionylcarnitine for increasing the levels of igf-1 |
| 01/09/2007 | CA2186844C Use of serotonin antagonists (5ht3) for treating fibromyalgia |
| 01/09/2007 | CA2142700C 3-oxo-pyrido(1,2-a)benzimidazole-4-carboxyl and 4-oxo-azepino(1,2-a)benzimidazole-5-carboxyl derivatives useful in treating central nervous system disorders |
| 01/04/2007 | US20070004914 enhance humoral and cell-mediated immune responses to vaccine antigens; 2-deoxy-2-amino- beta -D-glucopyranose (glucosamine) glycosidically linked to an cyclic aminoalkyl (aglycon) group; viricide; immunostimulant; antiischemic agent |
| 01/04/2007 | US20070004807 Methods using phenethanolamine derivatives for treatment of respiratory diseases |
| 01/04/2007 | US20070004718 Ion channel modulating compounds and uses thereof |
| 01/04/2007 | US20070004716 Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient |
| 01/04/2007 | US20070003556 Modified antibodies against cd22 and utilization thereof |
| 01/04/2007 | US20070003544 Combination therapy for treatment of autoimmune diseases using b- cell depleting/immunoregulatory antibody combination |
| 01/03/2007 | EP1739176A1 Decoy nucleic acid to synoviolin gene promoter |
| 01/03/2007 | EP1739081A1 Hydrazino-substituted heterocyclic nitrile compounds and use thereof |
| 01/03/2007 | EP1738768A1 Aqueous formulation for vecuronium bromide |
| 01/03/2007 | EP1738766A1 Preventive and/or therapeutic agent for disease accompanied by chronic muscle/skeleton pain |
| 01/03/2007 | EP1738755A1 Tablet containing branched chain amino acid and process for producing the same |
| 01/03/2007 | EP1738754A1 Solid pharmaceutical preparation |
| 01/03/2007 | EP1463487A4 Liposomal delivery of vitamin e based compounds |
| 01/03/2007 | CN1293192C Immunoregulation polynucleotide and using method thereof |
| 01/03/2007 | CN1293064C Deuterated 3-piperidinopropiophenone and medicaments containing said compounds |
| 01/03/2007 | CN1293053C 1-sulfonyl-4-aminoalkoxy indole derivatives as 5-ht6-receptor modulators for the treatment of cns-disorders |
| 01/02/2007 | US7157582 For example, 3S,4aR,6S,8aR Ethyl 6-(((5S)-5-(Ethoxycarbonyl)-3-oxopyrrolidinyl) methyl)-2-methoxycarbonyl-1,2,3,4,4a,5,6,7,8,8a-decahydroisoquinoline-3-carboxylate; for treating or preventing migraine |
| 01/02/2007 | US7157578 4-(2-butylamino)-2, 7-dimethyl-8-(2-methyl-6-methoxypyrid-3-YL) pyrazolo-[1,5-A]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands |
| 01/02/2007 | US7157480 Use of pramipexole to treat amyotrophic lateral sclerosis |
| 01/02/2007 | US7157454 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 01/02/2007 | US7157451 Cardiac arrhythmias; potassium channel function inhibitors; such as 7-(3,4-Dichlorophenyl)-6-(5-fluoro-1-methyl-1H-benzimidazol-2-yl)-4,7 -dihydro-5-(methoxymethyl)pyrazolo-(1,5-a)pyrimidine |
| 01/02/2007 | US7157433 Compounds, compositions as carriers for steroid/nonsteroid anti-inflammatory; antienoplastic and antiviral active molecules |
| 01/02/2007 | US7157420 Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
| 01/02/2007 | US7157241 Dipeptidyl peptidase IV (DPPIV); given sequences; homology with family of prolyl oligopeptidases; drug screening for enzyme inhibitors for DPPIV which could treat reproductive, inflammatory and metabolic disorders |
| 01/02/2007 | US7157240 MID 4460, a human tyrosine phosphatase family member and uses therefor |
| 01/02/2007 | CA2177602C N-substituted azabicycloalkane derivatives, their preparation and use |
| 12/30/2006 | CA2508691A1 Use of complement inhibitory proteins to treat spinal cord injury |
| 12/28/2006 | WO2006138038A1 Intralesional treatment of psoriasis |
| 12/28/2006 | WO2006137527A1 Thiazole derivative |
| 12/28/2006 | WO2006099480A3 Stress proteins and peptides and methods of use thereof |
| 12/28/2006 | WO2003072714A3 Follistatin domain containing proteins |
| 12/28/2006 | US20060293348 CSBP/p38 kinase inhibitor; antiinflammatory agent; inflammatory bowel disease; tuberculosis, atherosclerosis, muscle degeneration, cachexia, psoriatic arthritis, rheumatoid arthritis; 8-(2,4,6-trifluorophenyl)-4-(2,4-difluorophenyl)-2-(2-hydroxy-1-hydroxymethylethylamino)-8H-pyridio[2,3]pyrimidin-7-one |
| 12/28/2006 | US20060293326 2-Heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases |
| 12/28/2006 | DE202006010725U1 Composition containing modified oligonucleotide with achiral internucleotide phosphate bonds, useful for treating muscular atrophy or promoting muscle growth |
| 12/28/2006 | CA2633030A1 Intralesional treatment of psoriasis |
| 12/27/2006 | EP1736775A1 Novel ligand of g protein coupled receptor protein and use thereof |
| 12/27/2006 | EP1736541A1 Novel galectin 9 modification protein and use thereof |
| 12/27/2006 | EP1736474A1 Piperidine derivative |
| 12/27/2006 | EP1736470A2 Pyrimidine derivatives as CB2 cannabinoid receptor modulators |
| 12/27/2006 | EP1736469A2 Processes for the preparation of (R)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-Fluorophenyl)ethyl]-4-piperidinemethanol |
| 12/27/2006 | EP1736158A2 Use of 1- 4-(5-cyanoindol-3-yl)butyl -4-(2-carbamoylbenzofuran-5-yl)piperazine and its physiologically acceptable salts |
| 12/27/2006 | EP1734952A1 Protein kinase c inhibitors for the treatment of autoimmune diseases and of transplant rejection |
| 12/27/2006 | EP1443925B1 Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors |
| 12/27/2006 | EP1392276B1 Potentiation of therapeutic effects of polyunsaturated fatty acids |
| 12/27/2006 | EP1332372B1 Net, a transcription factor of the tcf family, as regulator of angiogenic factor expression |